| Bioactivity | DYRK2-IN-1 (Compd 54) is an orally bioavailable DYRK2 inhibitor, with an IC50 of 14 nM. DYRK2-IN-1 (Compd 54) can be used in the study of prostate cancer[1]. |
| Target | IC50: 14 nM (DYRK2). |
| Name | DYRK2-IN-1 |
| Formula | C29H31FN8O2S |
| Molar Mass | 574.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kai Yuan, et al. Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer. J Med Chem. 2023 Dec 14;66(23):16235-16256. |